Moderna to Host Investor Event - Analyst Day
Moderna (Nasdaq: MRNA) will host an Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
Management will present on Moderna's development and commercial strategy and key business considerations. A live webcast will be available at investors.modernatx.com under Events and Presentations. A replay will be archived on Moderna's website for at least 30 days following the presentation.
Moderna (Nasdaq: MRNA) ospiterà un Evento per gli investitori - Analyst Day alle 9:00 a.m. ET giovedì 20 novembre 2025.
Il management illustrerà la strategia di sviluppo e commerciale di Moderna e le principali considerazioni di business. Una trasmissione in diretta sarà disponibile su investors.modernatx.com nella sezione Eventi e Presentazioni. Una registrazione sarà archiviata sul sito di Moderna per almeno 30 giorni dopo la presentazione.
Moderna (Nasdaq: MRNA) organizará un Evento para inversores - Investor Day a las 9:00 a. m. ET el jueves 20 de noviembre de 2025.
La dirección presentará sobre la estrategia de desarrollo y comercial de Moderna y consideraciones comerciales clave. Habrá una transmisión en vivo disponible en investors.modernatx.com en la sección Eventos y Presentaciones. Se archivará una reproducción en el sitio web de Moderna durante al menos 30 días después de la presentación.
Moderna (나스닥: MRNA)는 Investor Event - Analyst Day를 2025년 11월 20일 목요일 동부 표준시 오전 9시에 개최합니다.
경영진은 Moderna의 개발 및 상업 전략과 주요 사업 고려사항을 발표할 예정입니다. 생중계는 investors.modernatx.com의 이벤트 및 프리젠테이션 섹션에서 시청할 수 있습니다. 프리젠테이션 후 최소 30일 동안 Moderna의 웹사이트에 재방송이 보관됩니다.
Moderna (Nasaq: MRNA) organisera un Événement Investisseurs - Investor Day à 9h00 ET le jeudi 20 novembre 2025.
La direction présentera la stratégie de développement et commerciale de Moderna et les principales considérations commerciales. Une diffusion en direct sera disponible sur investors.modernatx.com dans la rubrique Événements et Présentations. Une rediffusion sera déposée sur le site de Moderna pendant au moins 30 jours après la présentation.
Moderna (Nasdaq: MRNA) wird am Investor Event - Analyst Day ausrichten 9:00 a.m. ET am Donnerstag, dem 20. November 2025.
Das Management wird über Modenas Entwicklungs- und Geschäftsstrategie und wichtige geschäftliche Überlegungen berichten. Eine Live-Übertragung ist unter investors.modernatx.com im Bereich Events und Presentations verfügbar. Eine Wiedergabe wird für mindestens 30 Tage nach der Präsentation auf der Moderna-Website archiviert.
موديرنا (ناسداك: MRNA) ستستضيف فعالية المستثمرين - يوم المحللين في 9:00 صباحًا بتوقيت شرق الولايات المتحدة يوم الخميس 20 نوفمبر 2025.
سيقدم الإدارة استراتيجية التطوير والتسويق لـ Moderna واعتبارات أعمال رئيسة. ستكون هناك بث مباشر متاح على investors.modernatx.com ضمن قسم الفعاليات والعروض. ستُخَزَّن إعادة البث على موقع Moderna الإلكتروني لمدة لا تقل عن 30 يومًا بعد العرض.
Moderna (纳斯达克：MRNA) 将主办一个 投资者活动 - 分析师日，时间为 美东时间2025年11月20日星期四上午9:00。
管理层将就 Moderna 的 开发与商业策略以及关键的业务考量进行介绍。现场网络直播将可在 investors.modernatx.com 的“活动与演示”栏目中观看。演示结束后，回放至少会在 Moderna 的网站上保存 30 天。
- None.
- None.
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website
Webcast: investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Moderna's (MRNA) Investor Event - Analyst Day in 2025?
How can investors watch the Moderna (MRNA) Analyst Day webcast?
Will Moderna (MRNA) post a replay of the November 20, 2025 Analyst Day?
What topics will Moderna (MRNA) cover at the November 20, 2025 Analyst Day?
Where in the Moderna (MRNA) investor site is the Analyst Day webcast available?
